Nexalin Registers 5.75M Shares for Alumni Capital Resale, Reveals Exchange Cap Limits $15M Equity Line
NXL is trading near its 52-week low of $3.97 (0.8% above the low).
Summary
Nexalin registered 5.75 million shares for resale by Alumni Capital under its $15M equity line, but disclosed that Nasdaq's Exchange Cap limits actual issuance to only ~149,750 shares without stockholder approval. The filing also reveals recent ATM sales of $1.9M and a $189K consent fee paid to Alumni.
Key Events · Financing and Capital Events · NXL
-
Resale Registration Filed for $15M Equity Line
S-1/A registers 5,752,823 shares for resale by Alumni Capital LP, consisting of 5,600,000 AMPA shares, 112,500 commitment shares, and 40,323 warrant shares.
-
Exchange Cap Limits Access to $15M
Nasdaq Listing Rule 5635(d) caps AMPA issuance at approximately 149,750 shares without stockholder approval — only about 2.6% of the registered amount — meaning the company can access only a small fraction of the $15 million commitment.
-
Recent ATM Sales and Consent Fee
During the week ended October 2, 2026, Nexalin sold 219,593 ATM shares for ~$1.9M gross proceeds, paid Alumni Capital ~$189,000 (10% of gross proceeds) as a consent fee, and applied ~$378,000 to prepay the Streeterville note.
-
Going Concern and Nasdaq Equity Deficiency Persist
The filing reiterates substantial doubt about going concern and the requirement to demonstrate $2.5M minimum stockholders' equity by January 4, 2027, with equity at only $1,519,423 as of June 30, 2026.
Analysis · NXL · Industrial Applications And Services
This S-1/A makes the previously announced $15 million Alumni Capital equity line tradable by registering 5.75 million shares for resale. The critical new disclosure is the Exchange Cap: without stockholder approval, only about 149,750 shares can be issued under the AMPA — roughly 2.6% of the registered amount — meaning the company can access only a small fraction of the $15 million commitment. The filing also reveals the company sold 219,593 ATM shares for $1.9 million in early October, paid $189,000 to Alumni Capital as a consent fee, and applied $378,000 to prepay the Streeterville note. Against a backdrop of going-concern warnings, a $2.5M stockholders' equity deficiency due January 4, 2027, and a stock trading near its 52-week low, the constrained equity line raises questions about how Nexalin will fund operations through 2027.
How filings like this one have moved
In the 30 days to Oct 8, 2026, 28.6% of the 1679 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXL was trading at $4.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.4M. The 52-week trading range was $3.97 to $60.00. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.